Daniel Heintel

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 207 citations · Full text

Medicine, Hematology, Oncology +12

Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response

Antonia Lopez‐Girona, Daniel Heintel, Ling‐Hua Zhang et al. · British Journal of Haematology · 2011 · 179 citations · Full text

Medicine, Oncology, Pharmacology +17

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

Daniel Heintel, Dirk Kienle, Medhat Shehata et al. · Leukemia · 2005 · 158 citations

Life Sciences, Biochemistry, Hematology +13

High expression of cereblon (<i><scp>CRBN</scp></i>) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone

Daniel Heintel, Alberto Rocci, Heinz Ludwig et al. · British Journal of Haematology · 2013 · 123 citations · Full text

Medicine, Immunology, Pharmacology +16

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response

Ulrich Jäger, Michael Fridrik, Markus Zeitlinger et al. · Haematologica · 2012 · 107 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17